While IL-6 is often used as a marker for obesity-associated ‘meta-inflammation [26]’ measurement of plasma endotoxin levels (LPS), which were not assessed would be ideal and should be done in future studies. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.